Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Improving Cardiac Function After LVAD Implantation
NCT07666698Phase 2Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liquid metformin (Aspargo Labs) in heart failure (HF) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Incidence of Full Responder at 12 months. Started Jul 2026; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07666698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07666698.